BIOMM S.A.
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
Other Names/Subsidiaries
- Savicevic Participacoes SA
Latest on BIOMM S.A.
Things may be looking up in the US for adalimumab biosimilars, but Coherus BioSciences, Inc. 's decision to divest Yusimry (adalimumab-aqvh) saw analysts raise questions on the wider prospects for ri
Things may be looking up in the US for adalimumab biosimilars, but Coherus BioSciences, Inc. 's decision to divest Yusimry (adalimumab-aqvh) saw analysts raise questions on the wider prospects for ri
Biocon Limited has set out plans to compete in what it says is a $580m Brazilian market for semaglutide, after striking an exclusive licensing and supply agreement for its Ozempic generic with local
Lupin Limited ’s Q2 FY24 earnings saw an anticipated boost to gross margins post the launch of a much-awaited first generic to Boehringer Ingelheim GmbH ’s Spiriva Handihaler (tiotropium bromide) in